Corinne G Jolivalt
6PUBLICATIONS
4CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Mar 25, 2024
A muscarinic receptor antagonist reverses multiple indices of diabetic peripheral neuropathy: preclinical and clinical studies using oxybutynin.Carolina M Casselini, Henri K Parson, Katie E Frizzi
|Aug 15, 2022
Enhancement of Mitochondrial Function by the Neurogenic Molecule NSI-189 Accompanies Reversal of Peripheral Neuropathy and Memory Impairment in a Rat Model of Type 2 Diabetes.C G Jolivalt, M R Aghanoori, M C Navarro-Diaz
|May 14, 2022
Using Corneal Confocal Microscopy to Identify Therapeutic Agents for Diabetic Neuropathy.Corinne G Jolivalt, May Madi Han, Annee Nguyen
|Aug 02, 2020
Insulin deficiency, but not resistance, exaggerates cognitive deficits in transgenic mice expressing human amyloid and tau proteins. Reversal by Exendin-4 treatment.Matthew R King, Nicholas J Anderson, Mihaela Deciu
|Apr 25, 2020
Topical Delivery of Muscarinic Receptor Antagonists Prevents and Reverses Peripheral Neuropathy in Female Diabetic Mice.Corinne G Jolivalt, Katie E Frizzi, May Madi Han
|Sep 08, 2019
Amelioration of Both Central and Peripheral Neuropathy in Mouse Models of Type 1 and Type 2 Diabetes by the Neurogenic Molecule NSI-189.Corinne G Jolivalt, Alexandra Marquez, David Quach
Pageof 1
